No. |
Name |
CAS No. |
Remark |
61 |
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate |
161798-01-2 |
Febuxostat |
62 |
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate |
160844-75-7 |
Febuxostat |
63 |
endo-8-isopropyl-8-azabicyclo[3.2.1]octan-3-ol |
3423-25-4 |
Ipratropium bromide |
64 |
N-(8-Benzyl-8-azabicyclo[3.2.1]oct-3-yl-exo)-2-methylpropanamide |
376348-67-3 |
Maraviroc |
65 |
8-Benzyl-3-exo-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8- azabicyclo[3.2.1]octane |
423165-13-3 |
Maraviroc |
66 |
(1R,3s,5S)-3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane |
423165-07-5 |
Maraviroc |
67 |
3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane-p-toluenesulfonate |
423165-08-6 |
Maraviroc |
68 |
(betaS)-beta-Aminobenzenepropanoic acid methyl ester hydrochloride |
144494-72-4 |
Maraviroc |
69 |
(S)-tert-Butyl 3-oxo-1-phenylpropylcarbamate |
135865-78-0 |
Maraviroc |
70 |
4,4-Difluorocyclohexanecarboxylic acid |
122665-97-8 |
Maraviroc |
71 |
(+,-)-8,9-Difluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[i,j]quinoline-2-carboxylic acid |
80076-47-7 |
Nadifloxacin |
72 |
4-Hydroxypiperidine |
5382-16-1 |
|
73 |
Trans-4-isopropyl cyclohexane carboxylic acid |
1890988 |
Nateglinide |
74 |
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid |
137281-39-1 |
Pemetrexed disodium |
75 |
2-Benzylacrylic acid |
5669-19-2 |
Racecadotril |
76 |
Benzyl glycinate p-toluenesulfonate |
1738-76-7 |
Racecadotril |
77 |
3-Acetylthio-2-benzylpropanoic acid |
80969-99-9 |
Racecadotril |
78 |
4-chloro-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine |
199463-20-2 |
Revaprazan HCl |
79 |
1,2,3,4-tetrahydro-1-methyl- isoquinoline |
1119720 |
Revaprazan HCl |
80 |
N-(4-fluorophenyl)guanidine compound with Carbonic acid (2:1) |
925921-40-0 |
Revaprazan HCl |
This list is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights. |